David M Wilson

发表

4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.

Christopher Browning, Helen Connor, David M. Wilson, 2007, Journal of medicinal chemistry.

Demonstration of a genetic therapeutic index for tumors expressing oncogenic BRAF by the kinase inhibitor SB-590885.

Hieu T. Do, Meenhard Herlyn, David M. Wilson, 2006, Cancer research.

Antimalarial drug discovery: recent progress and future directions.

Félix Calderón, Francisco-Javier Gamo, David M. Wilson, 2013, Progress in medicinal chemistry.